First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma - Liau, Linda M.; Ashkan, Keyoumars; Tran, David D.; Campian, Jian L.; Trusheim, John E.; Cobbs, Charles S.; Heth, Jason A.; Salacz, Michael; Taylor, Sarah; D’Andre, Stacy D.; Iwamoto, Fabio M.; Dropcho, Edward J.; et al. (Journal of translational medicine, 2018)
Keywords: Brain cancer; Cancer therapies; Cancer vaccines; Chemoradiotherapy; Clinical trials; Dendritic cell; Dendritic cells; Enrollments; Gene expression; Genetic aspects; Glioblastoma; Glioblastomas; Immunotherapy; Medical prognosis; Patients; Physiological aspects; Prevention; Radiation therapy; Surgery; Temozolomide; Vaccine; Vaccines; United States; United Kingdom; Canada; United States--US; Dendritic cell; Vaccine; Immunotherapy; Glioblastoma